Literature DB >> 16698826

Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both?

D E Newby1, S J Cowell, N A Boon.   

Abstract

Aortic stenosis is the most common adult heart valve condition seen in the Western world and its incidence continues to rise. No established disease modifying treatments retard progression of the stenotic process. Recent insights into the pathogenesis of calcific aortic stenosis suggest that the disease mimics atherosclerosis. The natural history and progression of calcific aortic stenosis are described with particular emphasis on new and emerging medical treatments that may modify the disease process. In particular, statins and angiotensin converting enzyme inhibitors appear to hold promise but definitive evidence from large clinical trials is awaited.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16698826      PMCID: PMC1860674          DOI: 10.1136/hrt.2005.066852

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  28 in total

1.  Are atherosclerotic processes involved in aortic-valve calcification?

Authors:  E R Mohler
Journal:  Lancet       Date:  2000-08-12       Impact factor: 79.321

2.  Progression of aortic valve sclerosis and aortic valve stenosis: what is the role of statin treatment?

Authors:  Francesco Antonini-Canterin; Bogdan A Popescu; Guoqian Huang; Renata Korcova-Miertusova; Dante Rivaben; Pompilio Faggiano; Daniela Pavan; Rita Piazza; Angiola Bolis; Antonio Ciavattone; Alberto Ruggiero; Gian Luigi Nicolosi
Journal:  Ital Heart J       Date:  2005-02

3.  Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography.

Authors:  T Q Callister; P Raggi; B Cooil; N J Lippolis; D J Russo
Journal:  N Engl J Med       Date:  1998-12-31       Impact factor: 91.245

4.  Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome.

Authors:  C M Otto; I G Burwash; M E Legget; B I Munt; M Fujioka; N L Healy; C D Kraft; C Y Miyake-Hull; R G Schwaegler
Journal:  Circulation       Date:  1997-05-06       Impact factor: 29.690

5.  A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications.

Authors:  Ali Ahmed; Robert M Centor; Michael T Weaver; Gilbert J Perry
Journal:  Am Heart J       Date:  2005-04       Impact factor: 4.749

6.  Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly.

Authors:  C M Otto; B K Lind; D W Kitzman; B J Gersh; D S Siscovick
Journal:  N Engl J Med       Date:  1999-07-15       Impact factor: 91.245

7.  Predictors of outcome in severe, asymptomatic aortic stenosis.

Authors:  R Rosenhek; T Binder; G Porenta; I Lang; G Christ; M Schemper; G Maurer; H Baumgartner
Journal:  N Engl J Med       Date:  2000-08-31       Impact factor: 91.245

8.  Angiotensin-converting enzyme inhibitors and change in aortic valve calcium.

Authors:  Kevin D O'Brien; Jeffrey L Probstfield; Michael T Caulfield; Khurram Nasir; Junichiro Takasu; David M Shavelle; Audrey H Wu; Xue-Qiao Zhao; Matthew J Budoff
Journal:  Arch Intern Med       Date:  2005-04-25

9.  A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.

Authors:  S Joanna Cowell; David E Newby; Robin J Prescott; Peter Bloomfield; John Reid; David B Northridge; Nicholas A Boon
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

10.  Induction of local angiotensin II-producing systems in stenotic aortic valves.

Authors:  Satu Helske; Ken A Lindstedt; Mika Laine; Mikko Mäyränpää; Kalervo Werkkala; Jyri Lommi; Heikki Turto; Markku Kupari; Petri T Kovanen
Journal:  J Am Coll Cardiol       Date:  2004-11-02       Impact factor: 24.094

View more
  12 in total

1.  Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.

Authors:  Ashvin R Kamath; Ramdas G Pai
Journal:  Int J Angiol       Date:  2008

Review 2.  Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Authors:  Nalini M Rajamannan; Frank J Evans; Elena Aikawa; K Jane Grande-Allen; Linda L Demer; Donald D Heistad; Craig A Simmons; Kristyn S Masters; Patrick Mathieu; Kevin D O'Brien; Frederick J Schoen; Dwight A Towler; Ajit P Yoganathan; Catherine M Otto
Journal:  Circulation       Date:  2011-10-18       Impact factor: 29.690

3.  Calcific aortic stenosis: a disease ready for prime time.

Authors:  Nalini M Rajamannan
Journal:  Circulation       Date:  2006-11-07       Impact factor: 29.690

Review 4.  An undiagnosed bicuspid aortic valve can result in severe left ventricular failure.

Authors:  Sagar Saha; Rachel Bastiaenen; Martin Hayward; Jean R McEwan
Journal:  BMJ       Date:  2007-02-24

5.  The effect of angiotensin-converting enzyme inhibitors and statins on the progression of aortic sclerosis and mortality.

Authors:  Reza Ardehali; Nicholas J Leeper; Andrew M Wilson; Paul A Heidenreich
Journal:  J Heart Valve Dis       Date:  2012-05

Review 6.  Modulating the nitric oxide - cyclic GMP pathway in the pressure-overloaded left ventricle and group II pulmonary hypertension.

Authors:  B R Lindman; M M Chakinala
Journal:  Int J Clin Pract Suppl       Date:  2010-11

7.  Valvular aortic stenosis: a proteomic insight.

Authors:  Felix Gil-Dones; Tatiana Martin-Rojas; Luis F Lopez-Almodovar; Fernando de la Cuesta; Veronica M Darde; Gloria Alvarez-Llamas; Rocio Juarez-Tosina; Gemma Barroso; Fernando Vivanco; Luis R Padial; Maria G Barderas
Journal:  Clin Med Insights Cardiol       Date:  2010-02-04

8.  Low-density lipoprotein and aortic stenosis.

Authors:  Nalini M Rajamannan
Journal:  Heart       Date:  2008-09       Impact factor: 5.994

Review 9.  Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology.

Authors:  Nalini M Rajamannan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-23       Impact factor: 4.733

10.  Evaluation and management of aortic valve and root disease.

Authors:  John B de Graft-Johnson; Thomas G Gleason
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.